HomeCTMX • NASDAQ
add
CytomX Therapeutics Inc
Previous close
$4.70
Day range
$4.70 - $4.87
Year range
$0.40 - $8.21
Market cap
1.04B USD
Avg Volume
9.75M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 663.00K | -98.26% |
Operating expense | 25.80M | 26.36% |
Net income | -26.51M | -240.44% |
Net profit margin | -4.00K | -8,169.61% |
Earnings per share | -0.22 | -195.65% |
EBITDA | -24.62M | -236.09% |
Effective tax rate | -0.20% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 137.05M | 36.20% |
Total assets | 151.57M | 25.75% |
Total liabilities | 52.56M | -56.56% |
Total equity | 99.01M | — |
Shares outstanding | 170.19M | — |
Price to book | 8.10 | — |
Return on assets | -40.56% | — |
Return on capital | -58.11% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -26.51M | -240.44% |
Cash from operations | -23.24M | -16.75% |
Cash from investing | -14.42M | -195.27% |
Cash from financing | 16.64M | 640.02% |
Net change in cash | -21.02M | -732.77% |
Free cash flow | -8.26M | 59.58% |
About
Founded
2008
Headquarters
Website
Employees
69
